Bafna Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 44 | 39.51 | 36.65 |
| Operating Expense | 38.69 | 35.24 | 31.19 |
| Net Profit | 2.75 | 1.84 | 3.12 |
| Net Profit Margin | 6.25% | 4.66% | 8.51% |
| Earning Per Share | 1.16 | 0.78 | 1.32 |
| EBIDTA | 5.31 | 4.27 | 5.45 |
| Effective Tax Rate | -2.45% | 0% | 0% |
Particulars
Mar 2026
Revenue44
Operating Expense38.69
Net Profit2.75
Net Profit Margin6.25
Earning Per Share1.16
EBIDTA5.31
Effective Tax Rate-2.45
